Addition of fresh frozen plasma as a source of complement to rituximab in advanced chronic lymphocytic leukaemia.
Klepfish
Abraham
A
Blood Bank and Haematology Department, E Wolfson Medical Centre, Holon, Israel. klepfish@zahav.net.il
Schattner
Amichai
A
Ghoti
Hussam
H
Rachmilewitz
Eliezer A
EA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D010949:Plasma; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D000069283:Rituximab